Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Risultato della ricerca: Contributo in rivistaArticolo in rivista

151 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia'. Insieme formano una fingerprint unica.

Medicine and Dentistry